Human T-lymphocyte activation antigen CD80 / B7-1 (CD80) Protein

Este producto es parte de CD80 molecule
Product Graph
429€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human T-lymphocyte activation antigen CD80 / B7-1 (CD80) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx655966
tested applications
ELISA

Description

Human T-lymphocyte activation antigen CD80 / B7-1 (CD80) Protein is a recombinant active Human protein.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
T-lymphocyte activation antigen CD80 / B7-1 (Anti-CD80)
Host
293F cells
Assay Type
Activity: Active
Biological Activity: EC50: 0.412 µg/ml
A functional binding ELISA assay was conducted to detect the interaction of recombinant Human CD80 with recombinant human CD86. Briefly, serial dilutions of recombinant rat Human T-lymphocyte activation antigen CD80 / B7-1 (CD80) Protein were carried out in PBS, 0.01 % BSA (pH 7.4). Duplicate samples of 100 µl were transferred to microtiter wells pre-coated with CD86 and incubated for 1h at 37 °C. Wells were washed with PBST 3 times and incubated with Streptavidin-HRP for 40 minutes, then aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37 °C. Finally, add 50 µl stop solution to the wells and read at 450 nm immediately. 
Sequence Fragment: Val35-Asn242
Tag: N-terminal His tag
Origin
Human
Conjugation
Unconjugated
Observed MW
Calculated MW: 25.5kDa
Observed MW (SDS-PAGE): 40-60 kDa

Possible reasons why the actual band size differs from the predicted band size:
1. Splice variants. Alternative splicing may create different sized proteins from the same gene.
2. Relative charge. The composition of amino acids may affect the charge of the protein.
3. Post-translational modification. Phosphorylation, glycoslyation, methylation etc. may affect the band size.
4. Post-translational cleavage. Many proteins are synthesised as pro-proteins, and then cleaved to give the active form.
5. Polymerisation of the target protein. Dimerisation, multimerisation etc. will increase the band size observed.
Expression
Recombinant
Purity
> 95%
Size 1
50 µg
Size 2
100 µg
Size 3
200 µg
Size 4
500 µg
Size 5
1 mg
Form
Lyophilized
Tested Applications
ELISA
Buffer
Prior to lyophilization: PBS, pH 7.4, containing 5% Trehalose.
Availability
Shipped within 5-7 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
UniProt ID
P33681
Alias
B7,BB1,B7-1,B7.1,LAB7,CD28LG,CD28LG1,Activation B7-1 antigen,CTLA-4 counter-receptor B7.1,T-lymphocyte activation antigen CD80
Background
Protein CD80
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in 10 mM PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in 10 mM PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Endotoxin Level: < 1.0 EU/µg (determined by the LAL method)
Concentration: Prior to lyophilization: 1100 µg/ml

Descripción

Related Products

APC-30024

APC Anti-Mouse CD80(16-10A1)

Ver Producto
APC-30041

APC Anti-Human CD80(2D10)

Ver Producto
EH0088

Human CD80 (T-lymphocyte activation antigen CD80) ELISA Kit

Ver Producto